ClinConnect ClinConnect Logo
Search / Trial NCT06057909

A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease

Launched by MAYO CLINIC · Sep 21, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how conditions like Lewy Body Disease and Alzheimer’s Disease affect the brain, memory, thinking, and movement. Researchers want to learn more about these diseases by measuring things like memory abilities, brain activity, and daily functioning in both healthy individuals and those diagnosed with these conditions. They will use various methods, including brain scans, to gather this information.

To participate, individuals must be English speakers and willing to undergo health assessments and brain imaging tests. They need to have a study partner, like a family member or friend, who can help monitor their daily activities. This study is looking for healthy volunteers as well as people who have been diagnosed with Lewy body disease or Alzheimer’s by a qualified neurologist. Participants can expect to be involved in assessments that explore their cognitive and physical abilities, and they have the right to withdraw from the study at any time if they choose. It's important to note that individuals with certain medical conditions or those who are pregnant or nursing cannot participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Use English as their primary language.
  • Be willing to undergo health and cognitive assessments, as well as brain MRI and EEG study.
  • Will be encouraged to have an available study partner (also called a "co-participant") who is familiar with the participant's daily functioning.
  • This study will be limited to healthy individuals, and patients who have a clinical diagnosis made by a board-certified neurologist of Lewy body disease or Alzheimer disease.
  • All individuals must be capable of providing informed consent and complying with the trial procedures. Realizing the challenge of obtaining informed consent from cognitively impaired individuals, time is specifically scheduled to foster an informative, supportive interview with the participant and caregiver/legal guardian (typically a spouse or child according to Arizona law and IRB guidelines).
  • Ongoing participation will be maintained by strict adherence to inclusion/exclusion criteria, clinical appropriateness (as determined by participant's physician and proxy/family), as well as by expressed wishes of family members/caregivers/proxy discussed at each study visit (as appropriate).
  • All participants will receive copies of the signed ICFs (including signatures of those obtaining consent).
  • All participants have the right to withdraw from the study at any time.
  • Exclusion Criteria:
  • Individuals will be excluded if they have significant sensory (visual and hearing) deficits or major medical or psychiatric illnesses which would limit participation.
  • Participants will also be excluded if they have history of other major neurologic disorders including stroke, epilepsy, meningitis/encephalitis, metabolic or toxic encephalopathy, penetrating or severe closed head injury, brain tumor/other structural lesion, other primary movement disorders (such as essential tremor, dystonia, chorea, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome).
  • In addition, as necessitated by the risks of Magnetic Resonance Imaging (MRI), patients who have any type of implanted electrical device (such as a cardiac pacemaker or a neurostimulator including deep brain stimulation), or a certain type of metallic clip in their body (i.e., an aneurysm clip in the brain), are not eligible for participation in the MRI portion of the study. Individuals who experience claustrophobic anxiety will also be excluded from participation.
  • Women who are or might be pregnant and nursing mothers are not eligible.
  • If the subject is a woman of childbearing potential, due to unknown risks to the fetus, they must have a pregnancy test. Individuals who have a history metalworking involving cutting processes such as grinding, filing, shaving, and threading, or history of eye injury involving metal, will also be excluded unless they have had prior documented radiological clearance for MRI.

About Mayo Clinic

Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.

Locations

Scottsdale, Arizona, United States

Patients applied

0 patients applied

Trial Officials

Shannon Chiu, MD

Principal Investigator

Mayo Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported